Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AAD consensus statement on psoriasis therapies

Jeffrey P Callen, Gerald G Krueger, Mark Lebwohl

    Journal of the American Academy of Dermatology
    |October 25, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial).

    Journal of the European Academy of Dermatology and Venereology : JEADV·2024
    Same author

    Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.

    Dermatology and therapy·2023
    Same author

    Response to letter to the editor "It's time to consider a new topical algorithm for psoriasis".

    Journal of the American Academy of Dermatology·2023
    Same author

    Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.

    American journal of clinical dermatology·2022
    Same author

    Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis.

    Dermatology and therapy·2022
    Same author

    Cryptococcal meningitis associated with interleukin-17 inhibitor use for psoriasis.

    Dermatologic therapy·2022
    Same journal

    Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Response to Xue et al, "Defining super-responders is not the same as predicting rituximab response in pemphigus".

    Journal of the American Academy of Dermatology·2026
    Same journal

    Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Defining super-responders is not the same as predicting rituximab response in pemphigus.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Eosinophilic fasciitis induced by checkpoint inhibitors: a retrospective multicenter case-series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.

    Journal of the American Academy of Dermatology·2026
    See all related articles